Pharmacogenetics of sulfonylurea: Presence of CYP2C9*2, CYP2C9*3 and a novel allele, CYP2C9*61, in Type 2 diabetes patients under sulfonylurea therapy
CYP2C9 is an important member of the cytochrome P450 gene family involved in the metabolism of 15% of the drugs including an oral antidiabetic agent sulfonylurea. This study aims to investigate the frequency of CYP2C9*2 and CYP2C9*3 alleles of the gene in the sulfonylurea treated diabetic subjects i...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
University of Karachi
2020-07-01
|
| Schriftenreihe: | Pakistan Journal of Pharmaceutical Sciences |
| Online-Zugang: | https://pjps.pk/single-article?id=cmrvyrh2200nbkw1zf8127fw6 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|